Goodbody Health announces partnership with Thriva

Goodbody Health Limited
(“Goodbody Health”, or the “Company”)

Phlebotomy Services Trial


Goodbody Health (AQSE: GDBY) is pleased to announce that it continues to make significant progress with extending its phlebotomy services, having signed a contract with Thriva Limited (“Thriva”). This partnership will initially start as a trial with 82 of the Goodbody clinics, but others are expected to be added and allows for a longer-term relationship after a successful trial.


Thriva is one of the UK’s largest health technology companies with over 500,000 customers. Thriva operates both in the corporate and consumer space and is actively pushing their venous draw services through this trial.


Goodbody has also published an updated strategy deck to include the phlebotomy services and other health initiatives it has in progress and planned for 2023 on its website at


George Thomas, Chief Executive Officer, said: “We are very excited about this trial with Thriva as it continues to utilise the network of phlebotomists and latest technology we have built, and will continue to build, to support Goodbody and its partners to provide customers with accurate results and increased positive outcomes.”


Tom Livesey, CTO, Co-Founder of Thriva, said: “Partnering with Goodbody further extends our reach for testing services, offering convenient and accessible clinics in an ever-growing network.


The Directors of the Company
accept responsibility for the contents of this announcement.

George Thomas
Chief Executive Officer
Goodbody Health Limited
+44 (0) 20 7971 1255
[email protected]

AQSE Corporate Advisor
Peterhouse Capital Limited
Guy Miller / Mark Anwyl
+44 (0) 20 7469 0930

Anne Tew
Chief Financial Officer
Goodbody Health Limited
+44 (0) 20 7971 1255
[email protected]

Notes to Editors:

Health Limited (AQSE: GDBY and OTCQB: GDBYF) is an aggregator of the
highest quality, most innovative range of health 
wellness services and products using
the latest technology.  With over 52 products today, tests include blood, genetic, covid and other diagnostic
solutions to meet today’s fast evolving consumer expectations
 with more than 200,000 tests completed to
date. A comprehensive portfolio of CBD based products complement the
wellness range.

as a trusted distributor and retailer of accredited
wellness products and diagnostic services, provid
es a unique ‘frontline’ healthcare service in the
local community 
with expertise to enable customers to manage their health care digitally and make considered choices for their ‘health span’. Our
products and services grow local level amenities through 
a network
of over 200 independent community providers
offering much needed revenue to pharmacists and 
others local
providers, while alleviating pressure on the NHS.


Useful Website and social media links:


Share on

Published on